Complications associated with percutaneous closure devices

Gonze, Mark D.; Sternbergh, W. Charles; Salartash, Khashayar; Money, Samuel R.

doi:10.1016/s0002-9610(99)00143-9

Cited by 54 publications

(34 citation statements)

References 10 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…However, despite the less invasive approach, serious adverse events including major vascular complications are still reported with an incidence of 7-15% [5][6][7]. Although vascular complications may affect procedural results, contributing factors have not been well defined [8,9].…”

Section: Introductionmentioning

confidence: 99%

Predictive Factors of Vascular Complications after Transcatheter Aortic Valve Implantation in Patients Treated with a Default Percutaneous Strategy

Vavuranakis

Kariori

Voudris

et al. 2013

Cardiovascular Therapeutics

View full text Add to dashboard Cite

show abstract

Section: Introductionmentioning

confidence: 99%

Predictive Factors of Vascular Complications after Transcatheter Aortic Valve Implantation in Patients Treated with a Default Percutaneous Strategy

Vavuranakis

Kariori

Voudris

et al. 2013

Cardiovascular Therapeutics

View full text Add to dashboard Cite

show abstract

“…(4)(5)(6)(7)(8)(9)(10)(11)(12)(13). Ischemic symptoms can be acute limb threatening ischemia (sometimes delayed) (7,(10)(11)(12)(13) or acute onset severe claudication (9,12).…”

Section: Discussionmentioning

confidence: 99%

Acute Claudication caused by Angio-Seal Closure Devices: a Report of Four Cases

Mattens

2008

Acta Chirurgica Belgica

View full text Add to dashboard Cite

Femoral artery closure devices are increasingly used after percutaneous arterial interventions to obtain hemostasis at the puncture site. Their efficacy and advantages in patient comfort are established. Nevertheless they can cause their own specific complications. In a five month's period we had to treat four patients with sudden onset invalidating claudication after the use of an Angio-Seal closure device. Malpositioning of the device led to the ischemic complications. We describe and illustrate the pre- and peroperative findings and the treatment. Interventionalists should monitor and register ischemic complications following the use of puncture site closure devices in order to try and minimize these. The occurrence of few serious complications can outweigh the relative small benefits these devices offer.

show abstract

“…The Angio-Seal has been shown to allow earlier ambulatory activity and reduce hospitalization to less than 24 h. 6 This device is simple to use after a suitable training period, although if incorrectly employed, problems such as embolization, infection, or thrombosis may occur. 4,[8][9][10][11][12] The impossibility of arterial access prompted us to use a transprosthetic access and the highly positive experience with the Angio-Seal persuaded us to employ this device in prosthetic surgery, even though this application has not been described. To our knowledge, this is the first report of using the Angio-Seal to achieve closure of the femoral prosthetic puncture site.…”

Section: Discussionmentioning

confidence: 99%

Using the Angio-Seal to Achieve Hemostasis in Prosthetic Endovascular Surgery: Report of Three Cases

et al. 2004

View full text Add to dashboard Cite

At least 10% of patients who undergo bilateral aortofemoral bypass are at risk of needing a reoperation for late prosthetic thrombosis because of reduced outflow as the disease progresses. To prevent occlusion of the prostheses, we performed endovascular surgery with transprosthetic access for distal stenosis. We report our experience of using the Angio-Seal with transprosthetic access after angioplasty in three patients who had undergone bilateral aortofemoral bypass. Hemostasis was achieved in all three patients. There were no complications, such as hemorrhage, hematoma, or prosthetic infection, and all three patients were discharged within 24 h. At the 12-, 15-, and 24-month follow-up, none of the patients had any sign of recurrent claudication. Using the Angio-Seal in bilateral aortofemoral bypass provided the means of treating distal stenosis by endovascular surgery with transprosthetic access. This method is both rapid and safe, and may broaden the indications for the endovascular treatment of distal arteriopathies in patients with vascular prostheses.

show abstract

Complications associated with percutaneous closure devices

Cited by 54 publications

References 10 publications

Predictive Factors of Vascular Complications after Transcatheter Aortic Valve Implantation in Patients Treated with a Default Percutaneous Strategy

Predictive Factors of Vascular Complications after Transcatheter Aortic Valve Implantation in Patients Treated with a Default Percutaneous Strategy

Acute Claudication caused by Angio-Seal Closure Devices: a Report of Four Cases

Using the Angio-Seal to Achieve Hemostasis in Prosthetic Endovascular Surgery: Report of Three Cases

Contact Info

Product

Resources

About